Scapa to Sell Megolon Plastic Compounding Business to Alphagary for £16.75 million

Following the announcement on 8 June of the proposed sale of the Megolon Division ("Megolon") subject to due diligence, the Board of Scapa announces today that Scapa UK Limited ("Scapa UK") has entered into a conditional agreement to sell the business and assets of Megolon to Alphagary Limited ("Alphagary"), a subsidiary of Rockwood Holdings Inc, for a consideration of £16.75 million in cash (before transaction costs and taxation), subject to possible adjustment by reference to stock value at Completion. It is the intention that the cash proceeds from this transaction will be applied to repay secured borrowings in full ahead of the expiry of the medium term facility in September 2007. The proposed disposal is expected to be earnings neutral in the short term.

In view of the size of the proposed disposal relative to the Group, the proposed disposal is conditional upon the approval of shareholders. A circular, incorporating notice of an extraordinary general meeting, is expected to be posted to shareholders shortly.

The proposed disposal is also conditional upon receipt of various merger control clearances and it is anticipated that Completion will take place at the end of September 2006.

Principal terms of the Proposed Disposal
Pursuant to the terms of the sale agreement, Alphagary will pay £16.75m in cash to Scapa UK on Completion. Alphagary is to acquire the fixed assets, intellectual property, stock and goodwill in Megolon, together with the Group's freehold property at Columbine Street, Openshaw, Manchester, and will take over the orders and other contracts of Megolon which are outstanding at Completion. The Group is to grant a licence to Alphagary in respect of that part of the property at Manchester Road, Ashton occupied by Megolon. The Group will also provide support to Alphagary pursuant to a transitional services arrangement.

Background to and reasons for the Disposal
During the second half of the year we completed a major review of the Company. Scapa has good technology in the specialist adhesive tape market where technical performance and service are paramount and good margins are attained. Unfortunately a number of poorly performing acquisitions and investments in past years give us little room for manoeuvre and as a first step we have decided to sell a number of our peripheral operations to pay down our debt and improve our financial position.

Whilst the performance of the Megolon compounding operations has continued to be satisfactory, it is not a core part of the Group’s ongoing business and the Board has concluded that the proposed disposal is in the best interests of Shareholders.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.